SafetyinNumbers Posted December 31, 2023 Posted December 31, 2023 1 hour ago, Viking said: What has been the return on the 8-year investment in BIAL? The fair value of BIAL has increased 92% over the past 8 years (from inception), which is a CAGR of 8.5%. (Yes, this simple analysis understates Fairfax's actual return because not all of the investment was made at the beginning.) Great analysis as usual Viking! Thank you! FWIW, FIH calculates their CAGR to Sept 30, 2023 on BIAL to be 12.8%.
Viking Posted December 31, 2023 Posted December 31, 2023 (edited) 1 hour ago, SafetyinNumbers said: Great analysis as usual Viking! Thank you! FWIW, FIH calculates their CAGR to Sept 30, 2023 on BIAL to be 12.8%. @SafetyinNumbers thanks for the input/help. I have edited my summary to include this. Edited December 31, 2023 by Viking
petec Posted January 4 Author Posted January 4 On 12/31/2023 at 6:58 PM, Viking said: Carrying value significantly understates the value of Fairfax's stake in Fairfax India today. Viking - thanks for working this through. I have been meaning to do it for ages! This is one thing I wish FFH would change in their reporting - the reported difference between carrying and fair value for equities would be more useful if it included FIH on a look-through basis. By my rough maths this adds $20-25/share to FFH's "BV at fair value".
petec Posted January 4 Author Posted January 4 On 12/29/2023 at 9:02 PM, bargainman said: Looking at my records I purchased FFH shares 2007-2013. So basically during the time where they looked like geniuses for making a billion dollars by purchasing credit default swaps... but then promptly lost that billion dollars by purchasing puts on the equity markets that had already dropped by fifty percent. At the time when Buffett was making deals left and right. Or at least that's how I remember it. You and me both. I then did a great job of adding every time markets went down and the stock spiked. Finally achieved some absolution by adding in size at the bottom of the covid selloff - first time I got it right and the only reason I feel good about how I managed the position The good thing is that my "hedge" via FFH put me in a psychological position to hold some great stocks 2010-2020, so actually I did OK despite having >25% in FFH at times. And then FFH took off like a rocket ship. Weird how things work out.
petec Posted January 4 Author Posted January 4 On 12/28/2023 at 2:45 PM, Jaygo said: A question is why do these companies not just index. if the business of insurance is good why have a side business of investing. There are some funds that do 20% a year. Why not leave it to those guys or the index and focus on your business of insurance? we all have dogs but when I look at ffh it’s seems like some real mutts. Blackberry, recipe corp with the crappiest restaurants, shipping companies, I’m not a billionaire nor so successful people know me on the streets, so instead of criticizing I’m just really curious about it. I actually think brk is the same and really hope Greg starts to unwind the investments portfolio so it makes up a much smaller part of the business. Using the proceeds to shrink the equity at these very reasonable prices compared to the greater market. Personally I think you are framing this wrong. Both FFH and BRK were built by investors who got into insurance for float. Insurance isn't a great business and neither of them has ever said it is. But done well, it can provide low cost funds for investing. Both companies are led by people with investing in their DNA who absolutely believe they can outperform the markets over time. I also find it amusing when people on investment boards, who are presumably there because they are interested in stockpicking and think it is worth doing, advise other people to index. Not a criticism, but always makes me smile.
Viking Posted January 4 Posted January 4 (edited) 5 hours ago, petec said: Viking - thanks for working this through. I have been meaning to do it for ages! This is one thing I wish FFH would change in their reporting - the reported difference between carrying and fair value for equities would be more useful if it included FIH on a look-through basis. By my rough maths this adds $20-25/share to FFH's "BV at fair value". @petec as i was working through my BIAL post it became clear to me that i needed to do a valuation post on Fairfax India. It should be out this weekend. Another layer of complexity with Fairfax India (and Recipe) is some shares are held in an ‘asset value note’ that was put on when Fairfax sold RiverStone Barbados a couple of years ago. Fairfax reports they ‘beneficially owned, and/or exercised control or direction over’ these shares so they should be included as shares Fairfax ‘owns’ today. I think the shares being held in the ‘asset value note’ are slowly shrinking - hopefully this continues in Q4 (yes, Fairfax will need to spend some $ to buy the shares). The ‘asset value note’ looks to me like another example of Fairfax using leverage to boost returns. The FFH-TRS is another example. When i do my next size ranking of Fairfax’s equity holdings i am going to try and include the positions held in the ‘asset value note’ and Fairfax India at fair value (i will use Fairfax India’s reported book value). I might also take a stab at some private holdings like AGT and Bauer. This will increase the size of the equity bucket. And likely boost estimates of the returns from the equity bucket. Edited January 4 by Viking
Jaygo Posted January 4 Posted January 4 5 hours ago, petec said: Personally I think you are framing this wrong. Both FFH and BRK were built by investors who got into insurance for float. Insurance isn't a great business and neither of them has ever said it is. But done well, it can provide low cost funds for investing. Both companies are led by people with investing in their DNA who absolutely believe they can outperform the markets over time. I also find it amusing when people on investment boards, who are presumably there because they are interested in stockpicking and think it is worth doing, advise other people to index. Not a criticism, but always makes me smile. I am in no way giving advice, it was a curiosity about the setup and logic. Prem and Warren have done well but as warren showed with his bet with the hedge funds that most do not beat the market. Another way of looking at it is if an insurance company with cheap float provides a leveraged investment return than even a market average will beat the market in a way.
Maverick47 Posted January 4 Posted January 4 On 12/31/2023 at 1:01 PM, SafetyinNumbers said: FWIW, FIH calculates their CAGR to Sept 30, 2023 on BIAL to be 12.8%. Am I missing something in the FIH chart you included? To me it seems to indicate a 12.0% CAGR for BIAL. The 12.8% figure seems to apply to Seven Islands….
SafetyinNumbers Posted January 4 Posted January 4 4 minutes ago, Maverick47 said: Am I missing something in the FIH chart you included? To me it seems to indicate a 12.0% CAGR for BIAL. The 12.8% figure seems to apply to Seven Islands…. Either a typo by me or I misread it. Apologies for the confusion.
MMM20 Posted January 4 Posted January 4 3 hours ago, Jaygo said: Another way of looking at it is if an insurance company with cheap float provides a leveraged investment return than even a market average will beat the market in a way. Tom Gayner has this figured out. Sounds like you want MKL.
Viking Posted January 4 Posted January 4 (edited) Fairfax India was launched in 2015. It has grown into a wonderful business for Fairfax. Solid collection of assets. Very well managed. Very good track record. Well positioned for the future. In this post we are going to get into the weeds of how Fairfax India is valued by its parent, Fairfax. Let me know if you think i have messed up with my math/logic/assumptions… that is how we all learn. How much of Fairfax India does Fairfax own? When Fairfax India was launched in 2015, Fairfax owned 28.1%. My math says Fairfax now owns 43.0% of Fairfax India, which is an increase of more than 50% over the past 8 years. Fairfax India is also now a much larger company - common shareholders equity has increased from $1 billion at inception in 2015, to $2.8 billion at Sept 30, 2023, which is an increase of 180%. So today, Fairfax owns 50% more of a company that has increased in size by 180%. That sounds great. But what does the math look like? How many shares of Fairfax India does Fairfax actually own? It can be a little confusing to understand exactly how many shares of Fairfax India that Fairfax actually owns. This is because some shares are held in an ‘asset value note’ that was put on when Fairfax sold RiverStone Barbados a couple of years ago. On Feb 16, 2022, when they added to their position, Fairfax confirmed they ‘beneficially owned, and/or exercised control or direction over’ a total of 58.4 million shares of Fairfax India. I am assuming that is the number of shares they ‘own’ today. A short history of the growth of Fairfax’s ownership of Fairfax India (total shares and %) can be found at the bottom of this post. Market value and carrying value What is the market value that Fairfax uses to value its stake in Fairfax India? To determine market value, Fairfax uses Fairfax India’s stock price, which at Dec 31, 2023, was $15.20/share. This gives a total market value to Fairfax’s position of $888 million. What is the carrying value that Fairfax uses to value its stake in Fairfax India? Carrying value is important. This is the value that finds its way into book value. And, as we know, book value is the ‘holy grail’ use by investors to value P/C insurance companies. In the 2022AR, Fairfax said the carrying value for their investment in Fairfax India was $10.78/share, or $630 million (using my share count of 58.4 million). What is the excess of market value over carrying value? It appears Fairfax’s book value is understating the market value of its stake in Fairfax India by about $250 million. (Yes, i know my dates are messed up… directionally, it appears Fairfax India’s carrying value at Fairfax is low). OK. Are we done? No. There is a wrinkle. Fairfax India’s stock price is a terrible measure to use to value Fairfax’s stake in Fairfax India. And that is because Fairfax India’s stock price trades at a severe discount to the fair value of the collection of companies that it owns. My guess is accounting standards require Fairfax to report carrying value and market/fair value the way they do. What should we do? Fairfax India has very good disclosures. We should simply use Fairfax India’s book value - that is the best measure of what the collection of assets they own are actually worth. What is the value of Fairfax’s stake if we use Fairfax India’s book value? Fairfax India has a book value of $20.89/share (at Sept 30, 2023), which puts the value of Fairfax’s stake at $1.22 billion (using my share count of 58.4 million). It appears Fairfax’s book value is understating the value of its stake in Fairfax India by about $590 million. That is much larger than our previous estimate of $250 million. If we use a fair value of $1.22 billion, this suggests Fairfax India is Fairfax’s 4th largest holding, along with Eurobank, Poseidon and FFH-TRS. These 4 holdings represent about 40% of Fairfax’s total equity exposure. What does Prem think about Fairfax India’s reported book value? Prem thinks that Fairfax India’s intrinsic value is ‘much higher’ than its reported book value. If Prem is right, then the value of Fairfax’s stake in Fairfax India is worth even more than $1.22 billion. Below are Prem’s comment from Fairfax’s 2022AR: Growth prospects Fairfax India reported a book value of $20.89/share at Sept 30, 2023. My guess is it will be well over $21 at Dec 30, 2023. Let’s assume Fairfax India grows BV/share at 10% in 2024, which would be $2.10/share. This would put Fairfax’s share of growth in BV at $123 million ($2.10/share x 58.4 million shares). This would also deliver a (very rough) high teens ROE. Is 10% growth in BV/share an aggressive assumption? No, I actually think it will prove to be conservative. Why? BIAL is now 47% of total investments at Fairfax India. Its value has gone sideways for the past 3 years - as a result of Covid. However, the airport is beginning its next significant growth phase (as second runway and recently completed Terminal 2 ramp up). An Anchorage IPO in 2024 could unlock significant value that has been building at BIAL. Two other private holdings in Fairfax India also might see IPO’s in 2024: NSE and SIS, which would likely unlock more value for Fairfax India. The remaining holdings of Fairfax India are well run companies and should continue to increase in value. If my rough math is accurate, Fairfax’s stake in Fairfax India is poised to grow in value by about $123 million in 2024. Some of this value will show up in the ‘share of profit of associates’ bucket. However, like the past 8 years, a large part of the value will likely not show up in Fairfax’s reported results. As a result, the gap between fair value and carrying value will continue to widen. Conclusion Since being launched in 2015, Fairfax India has quietly been growing like a weed. It is a great example of exceptional long term value creation by the team at Fairfax/Fairfax India/Fairbridge. However, the value creation has largely not been reflected/captured in Fairfax’s accounting results - especially book value. Fairfax India is a great example of how book value at Fairfax is understated. There are likely more examples. —————- Warren Buffett on book value Warren Buffett in 2018 decided to no longer publish the book value for Berkshire Hathaway as he felt it was no longer a useful tool for investors to use to value Berkshire Hathaway’s share price. I wonder how much longer book value will serve as a useful tool for investors to value Fairfax’s share price. “Second, while our equity holdings are valued at market prices, accounting rules require our collection of operating companies to be included in book value at an amount far below their current value, a mis-mark that has grown in recent years.” —————- Fairfax India: Summary of ‘total existing Indian investments’ At Sept 30, 2023, Fairfax India held total investments with a fair value of $3.376 billion. If we adjust for Q4 transactions (increase in BIAL and decrease in IIFL Finance): BIAL (manages BLR Airport) = 47% All other holdings = 53% Fairfax India Shareholders equity = $2.833 billion Debt = $500 million —————- A short history of Fairfax’s investment in Fairfax India Fairfax India was launched in 2015. At inception, Fairfax invested a total of $300 million ($10/share) for a 28.1% ownership position. Fairfax India did a second capital raise in January 2017 (at $11.75/share) and Fairfax participated to keep its ownership position of similar size (it was 30.2% at the end of 2017. Fairfax has also received two performance fees in shares of Fairfax India (2018 and 2021). Today Fairfax owns 58.4 million shares of Fairfax India. My rough math says they paid a total of $539 million or an average of $9.23/share. Share count at Fairfax India peaked at 152.9 million at December 31, 2018. Since that time, the share count has come down 11.2% to 135.7 million. With the stock trading well below book value, Fairfax India has been taking out shares on the cheap. Smart. With Fairfax’s share count going up and Fairfax India’s share count coming down, Fairfax has increased its ownership interest in Fairfax India from 28.1% in late 2015 to 43.0 at Sept 30, 2023. That is an increase of more than 50% over the past 8 years. That is a meaningful increase. ————— Summary of Fairfax India’s exceptional track record (at Sept 30, 2023) CAGR of ‘Total existing Indian Investments’ = 13.0% CAGR of ‘Total monetized Indian Investments’ = 17.5% From Fairfax India's Q3 Interim Report - Page 32 - https://www.fairfaxindia.ca/wp-content/uploads/FIH-2023-Q3-Interim-Report-Final.pdf ————— Summary of key metrics for Fairfax India (from 2022AR) Edited January 5 by Viking 1
petec Posted January 6 Author Posted January 6 On 1/4/2024 at 3:47 PM, Viking said: @petec as i was working through my BIAL post it became clear to me that i needed to do a valuation post on Fairfax India. It should be out this weekend. Another layer of complexity with Fairfax India (and Recipe) is some shares are held in an ‘asset value note’ that was put on when Fairfax sold RiverStone Barbados a couple of years ago. Fairfax reports they ‘beneficially owned, and/or exercised control or direction over’ these shares so they should be included as shares Fairfax ‘owns’ today. I think the shares being held in the ‘asset value note’ are slowly shrinking - hopefully this continues in Q4 (yes, Fairfax will need to spend some $ to buy the shares). The ‘asset value note’ looks to me like another example of Fairfax using leverage to boost returns. The FFH-TRS is another example. When i do my next size ranking of Fairfax’s equity holdings i am going to try and include the positions held in the ‘asset value note’ and Fairfax India at fair value (i will use Fairfax India’s reported book value). I might also take a stab at some private holdings like AGT and Bauer. This will increase the size of the equity bucket. And likely boost estimates of the returns from the equity bucket. We should definitely include the asset value note shares. Doesn't that expire soon? I have a feeling they have to buy back those shares. Good luck valuing AGT and Bauer! I'll be fascinated to see your workings.
Viking Posted January 6 Posted January 6 (edited) As of December 31, 2023, my guess is Fairfax has an investment portfolio that totals about $60 billion, with the split being roughly as follows: In this post we review the holdings in the equities ‘bucket.’ To value a holding we normally used current ‘market value,’ which is the stock price at Dec 31, 2023, multiplied by the number of shares Fairfax owns. For private holdings we use Fairfax’s latest reported market value (sometimes carrying value). Derivative holdings, like the FFH-TRS, are included at their notional value. Where we have done something ‘funky’ we provide an explanation (see ‘additional notes’ below). We have attempted to capture a value for each holding that we feel roughly reflects its ‘intrinsic’ or actual economic value to Fairfax. For Fairfax India and Recipe, some shares are held in an ‘asset value note’ that was put on when Fairfax sold RiverStone Barbados a couple of years ago. We used share counts that reflect what we think Fairfax actually owns/controls. (I think some Poseidon shares are also included in this note but I am not sure so I did not make an adjustment for this - so the Poseidon position below might be understated by about 9%). Additional notes: Atlas: $2,100 = 2,046 FV at Q3 + $50 Q4 earnings (likely low) Fairfax India: $1,220 = $20.89 BV at FIH.U x 58.4 million shares Recipe: $900 = ($17.25 CV at Dec 31, 2022 x 49.4 million shares) + $50 million (2023 earnings est) AGT Food Ingredients: $350 million. A guess; probably low. EBITDA was C$150 million in 2022. Mytilineos: includes exchangeable bonds John Keells: includes convertible debentures Ok, let’s get to the fun part of this post. What are some key take-aways? Below are mine. What are yours? 1.) Fairfax has a pretty concentrated portfolio The top 5 holdings make up 45% of the total The top 15 holdings make up close to 70% of the total 2.) Steady improvement in quality of the top 15 holdings over the past 6 years: What happened? New money has been invested at Fairfax very well (FFH-TRS, buying more of existing holdings) Some high quality businesses have continued to execute well (Fairfax India, Stelco) Some businesses, after years of effort, have turned around (Eurobank). Some businesses that were severely affected by Covid have emerged stronger (Thomas Cook India, BIAL, Recipe?) Some businesses were restructured/taken private (EXCO, AGT) and are now performing much better. Some low quality business were sold/merged/wound down (Resolute Forest Products, APR, Fairfax Africa). Some low quality businesses have shrunk in size due to poor results (BlackBerry, Farmers Edge, Boat Rocker). The important point is the quality of Fairfax’s largest holdings have steadily been increasing. And this should result in higher overall returns from the equity portfolio in the coming years. 3.) What rate of return should this collection of equity holdings be able to deliver in 2024? 12% return x $18 billion = $2.16 billion (made up of share of profit of associates + dividends + ‘other’ consolidated non-insurance co’s + investment gains) This looks like a reasonable target for 2024, looking at the solid prospects/earnings profiles of the top 15 holdings (with a 70% weighting). 4.) A slow shift away from mark-to-market holdings. Today, less than 50% of the total portfolio is held in the mark-to-market bucket. Back in 2019, my guess is closer to 80% of the total portfolio was held in the mark-to-market bucket. This shift should have the effect of smoothing Fairfax’s reported results moving forward, especially during bear markets. As a reminder, in Q1, 2020, Fairfax had $1.1 billion in unrealized losses (when the equity portfolio was much smaller). As more holdings shift to the ‘Associates’ and ‘Consolidated’ buckets, it is the trend in underlying earnings at the individual holdings that will matter to Fairfax’s reported results and not a stock price - earnings are much more consistent than a stock price. Lower volatility in reported earnings should help Fairfax’s valuation (as volatility is considered bad by Mr. Market). This shift will also start to create a Berkshire Hathaway problem for Fairfax: over time book value will become an increasingly poor tool to use to value Fairfax. Why? The value of the ’Associates’ and ‘Consolidated’ companies captured in book value each year will fall short of the increase in their true economic value. Fairfax India is a good example of this today. Eurobank is a holding to watch moving forward. Bottom line, Fairfax looks very well positioned today. But the story gets better: like the past 6 years, I expect the quality of Fairfax's equity holdings to continue to improve in 2024. That will improve future returns. And, like a virtuous circle, the growing cash flows will be re-invested growing the companies even more. Thoughts? Am I missing something? What number below is most wrong? Why? Edited January 6 by Viking
Thrifty3000 Posted January 7 Posted January 7 Thanks @Viking . It looks to me like the top 5 holdings alone could generate look-through earnings in the ballpark of $1 billion. Since the top 5 holdings represent about half the equity portfolio, it seems like your $1.8 billion earnings estimate for the equity portfolio is perfectly reasonable. Once again, thanks to your work, I’ll have to upwardly adjust my financial model. I have been underestimating the earning power of the equity portfolio.
SafetyinNumbers Posted January 8 Posted January 8 1 hour ago, Thrifty3000 said: Thanks @Viking . It looks to me like the top 5 holdings alone could generate look-through earnings in the ballpark of $1 billion. Since the top 5 holdings represent about half the equity portfolio, it seems like your $1.8 billion earnings estimate for the equity portfolio is perfectly reasonable. Once again, thanks to your work, I’ll have to upwardly adjust my financial model. I have been underestimating the earning power of the equity portfolio. I think most investors including analysts are focused on the downside so they attribute little or no returns to the equity portfolio. Since the stock is so cheap there is no reason to include realistic estimates. It will be interesting if we see that change as they continue to beat estimates and if the stock begins to rerate. The same might hold true for some of the equity holdings. No earnings growth is expected from Eurobank despite really strong momentum. They like Fairfax will have a lot of excess capital to reinvest after dividends. At 5x earnings analysts don't have a reason to be optimistic here either. My theory is that both stocks will rerate faster once earnings estimates start going up because that's what quants focus on and most active capital is tied to quant screens in one way or another. For Fairfax, that can't' happen unless analysts start building in higher returns from the equity portfolio. Most won't bother until the market forces them to. Maybe that's starting to happen.
Viking Posted January 8 Posted January 8 (edited) 4 hours ago, Thrifty3000 said: Thanks @Viking . It looks to me like the top 5 holdings alone could generate look-through earnings in the ballpark of $1 billion. Since the top 5 holdings represent about half the equity portfolio, it seems like your $1.8 billion earnings estimate for the equity portfolio is perfectly reasonable. Once again, thanks to your work, I’ll have to upwardly adjust my financial model. I have been underestimating the earning power of the equity portfolio. @thrifty For fun, here are some rough numbers for 2024: Poseidon = $200 to $250 Eurobank = $400 to $450 FFH-TRS = $400 to $500 Fairfax India = $125 Recipe = $75 Top 5 could deliver $1.2 billion in ‘value creation’ on their own. The FFH-TRS position is already up $120 million one week into the new year. If Eurobank announces the initiation of a dividend when they report YE results that likely will pop their share price. Of interest, much of the TRS notional position is not captured in BV (just the gains are captured in BV). So gains in that position really helps the ROE math. Edited January 8 by Viking
Haryana Posted January 11 Posted January 11 Newswire going verbose on negligible Orla, again! Fairfax Announces Acquisition of Additional Orla Shares TORONTO (Globe Newswire) January 10, 2024
srtadimeti Posted January 11 Posted January 11 https://m.economictimes.com/news/india/indias-big-advantage-is-that-two-thirds-of-the-economy-is-consumer-oriented-says-fairfax-boss-prem-watsa/articleshow/106711744.cms?_gl=1*1byev4h*_ga*MTIzOTEwODM4OS4xNjk3NjI3MjU2*_ga_WZ3Z4GGVRC*MTcwNDk2NzgyOS41LjEuMTcwNDk2ODAxMS42MC4wLjA.*_gcl_au*MTYyMDYzMDU3Ny4xNzAwNTgzMzI0 Fairfax to double investment in India over the next five years.
nwoodman Posted January 11 Posted January 11 3 hours ago, srtadimeti said: https://m.economictimes.com/news/india/indias-big-advantage-is-that-two-thirds-of-the-economy-is-consumer-oriented-says-fairfax-boss-prem-watsa/articleshow/106711744.cms?_gl=1*1byev4h*_ga*MTIzOTEwODM4OS4xNjk3NjI3MjU2*_ga_WZ3Z4GGVRC*MTcwNDk2NzgyOS41LjEuMTcwNDk2ODAxMS42MC4wLjA.*_gcl_au*MTYyMDYzMDU3Ny4xNzAwNTgzMzI0 Fairfax to double investment in India over the next five years. I’ll take the $84 bn market cap right now if it’s in the offing , kind of thought that might be a story for 2030+. However very pleasing to see that they have some other assets in mind other than, perhaps, a particular bank
Haryana Posted January 11 Posted January 11 7 hours ago, nwoodman said: I’ll take the $84 bn market cap right now if it’s in the offing , kind of thought that might be a story for 2030+. However very pleasing to see that they have some other assets in mind other than, perhaps, a particular bank Good catch on the $84 billion blunder even though cannot disagree that much if they are expressing their opinion of fair value in CAD$. Here is the link to more detailed interview - https://economictimes.indiatimes.com/news/company/corporate-trends/indians-can-dream-now-the-potential-is-enormous-prem-watsa-chairman-fairfax-financial-holdings/articleshow/106716893.cms
nwoodman Posted January 15 Posted January 15 MS just upgraded their PT for Eurobank from €2.01 to €2.33. They had this to say: ‘We upgrade Eurobank to Overweight: The Greek banks are on the top of our order of preference within our CEEMEA Banks coverage, given the most attractive risk reward. Our PT for Eurobank moves up by ~16% following a 7% and 12% upgrade to 2024 and 2025 estimates on better NII, consolidation of Hellenic Bank acquisition in Cyprus in 2025. On our revised PT of EUR2.33 we have ~40% upside to the stock from current levels.” and “The Greek banks are expected to restate dividend payouts with FY23 results. With growing capital ratios into 2025, we see upside optionality from excess capital being returned to shareholders in higher dividend payouts, and/or higher earnings growth via deployment into asset growth. Eurobank is testament to this, with its planned Hellenic Bank acquisition. Our estimates now assume higher payouts of 35-50% for the Greek banks by 2025. Our analysis suggests 140-520bps of excess capital over minimum management buffers by 2025 (620-940bps vs min regulatory requirement) for the Greek banks, with NBG standing out. We show below the potential upside of up to 9-38% to earnings from deployment of this excess capital over management buffers. We expect the reinstatement of dividends and return of capital to shareholders to be a key catalyst for the Greek banks in the coming months.” Report attached for those interested EEMEA_20240115_0001.PDF
SafetyinNumbers Posted January 15 Posted January 15 4 hours ago, nwoodman said: MS just upgraded their PT for Eurobank from €2.01 to €2.33. They had this to say: ‘We upgrade Eurobank to Overweight: The Greek banks are on the top of our order of preference within our CEEMEA Banks coverage, given the most attractive risk reward. Our PT for Eurobank moves up by ~16% following a 7% and 12% upgrade to 2024 and 2025 estimates on better NII, consolidation of Hellenic Bank acquisition in Cyprus in 2025. On our revised PT of EUR2.33 we have ~40% upside to the stock from current levels.” and “The Greek banks are expected to restate dividend payouts with FY23 results. With growing capital ratios into 2025, we see upside optionality from excess capital being returned to shareholders in higher dividend payouts, and/or higher earnings growth via deployment into asset growth. Eurobank is testament to this, with its planned Hellenic Bank acquisition. Our estimates now assume higher payouts of 35-50% for the Greek banks by 2025. Our analysis suggests 140-520bps of excess capital over minimum management buffers by 2025 (620-940bps vs min regulatory requirement) for the Greek banks, with NBG standing out. We show below the potential upside of up to 9-38% to earnings from deployment of this excess capital over management buffers. We expect the reinstatement of dividends and return of capital to shareholders to be a key catalyst for the Greek banks in the coming months.” Report attached for those interested EEMEA_20240115_0001.PDF 3.88 MB · 9 downloads Thanks for sharing. The EUROB position is ~US$100/share so a significant chunk of the share price. Coincidentally, Fairfax’s share of EUROB’s expected dividend for 2024 is about US$5/share or the same amount as FFH’s dividend increase. European bank valuations are low so lots of room to rerate but hard to bet on. It might mean that earnings estimates are too low though as high returns are available for excess capital like the Hellenic Bank acquisition.
Viking Posted January 15 Posted January 15 (edited) 4 hours ago, nwoodman said: MS just upgraded their PT for Eurobank from €2.01 to €2.33. They had this to say: ‘We upgrade Eurobank to Overweight: The Greek banks are on the top of our order of preference within our CEEMEA Banks coverage, given the most attractive risk reward. Our PT for Eurobank moves up by ~16% following a 7% and 12% upgrade to 2024 and 2025 estimates on better NII, consolidation of Hellenic Bank acquisition in Cyprus in 2025. On our revised PT of EUR2.33 we have ~40% upside to the stock from current levels.” and “The Greek banks are expected to restate dividend payouts with FY23 results. With growing capital ratios into 2025, we see upside optionality from excess capital being returned to shareholders in higher dividend payouts, and/or higher earnings growth via deployment into asset growth. Eurobank is testament to this, with its planned Hellenic Bank acquisition. Our estimates now assume higher payouts of 35-50% for the Greek banks by 2025. Our analysis suggests 140-520bps of excess capital over minimum management buffers by 2025 (620-940bps vs min regulatory requirement) for the Greek banks, with NBG standing out. We show below the potential upside of up to 9-38% to earnings from deployment of this excess capital over management buffers. We expect the reinstatement of dividends and return of capital to shareholders to be a key catalyst for the Greek banks in the coming months.” Report attached for those interested EEMEA_20240115_0001.PDF 3.88 MB · 8 downloads @nwoodman thanks for all the info on Eurobank. It has been invaluable. MS new price target of €2.33/share is 45% higher than where shares closed 2023 (€1.61/share). Fairfax’s position in Eurobank was worth $2 billion at year end. 45% upside = $900 million gain. That is not on anyones radar right now (analysts who follow Fairfax). Eurobank is a monster-sized position for Fairfax - and it is poised to get much larger. It really is amazing the turnaround that has happened at Eurobank over the past 3 years. It has been super interesting to watch the management team at Eurobank for the past 3 years - a steady stream of good decisions. The Hellenic Bank acquisition looks like it could be very good. And i can’t wait to see what the management team at Eurobank does in 2024. To use an old hockey analogy: for years, out of necessity (an economic depression will do that), Eurobank was playing Chris Chelios defense (ugly, brutal). Now they have shifted to playing an Edmonton Oiler offense (I am taking about the Gretzky, Messier, Kurri, Coffee version). As a fan, I much prefer watching the ‘Oilers in their prime’ version. Edited January 15 by Viking
nwoodman Posted January 15 Posted January 15 @SafetyinNumbers, @Viking my pleasure and it still looks undervalued. As always we take analysts with a grain of salt but I have enjoyed Nida Iqbal’s (MS Analyst) work over the last couple of years. It’s getting close to fruition that we bought a position in a bank, a shipping business, an airport plus an option on the fastest growing insurance sector with the ops and other positions throw in for free. They were some pretty helpful conversations only a couple of years ago. I find Fairfax, at times a little flighty, but their backing of Eurobank hopefully cries to the market patient and supportive capital.
nwoodman Posted January 15 Posted January 15 28 minutes ago, Viking said: To use an old hockey analogy: for years, out of necessity (an economic depression will do that), Eurobank was playing Chris Chelios defense (ugly, brutal). Now they have shifted to playing an Edmonton Oiler offense (I am taking about the Gretzky, Messier, Kurri, Coffee version). As a fan, I much prefer watching the ‘Oilers in their prime’ version. Nicely put
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now